SERTAD1 and urinary bladder carcinoma: Especially, TIMER36 analysis showed significant overexpression of TRIP-Br-1 in the breast (BRCA), bladder carcinoma (BLCA), CHOL, COAD, ESCA, head and neck squamous cell carcinoma (HNSC), kidney renal papillary cell carcinoma (KIRP), and LUSC with respect to normal tissue samples in TCGA datasets.